Cargando…
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development
BACKGROUND: Therapeutic agents with novel mechanisms of action are needed to combat the growing epidemic of type 2 diabetes (T2D) and related metabolic syndromes. Liver X receptor (LXR) agonists possess preclinical efficacy yet produce side effects due to excessive lipogenesis. Anticipating that man...
Autores principales: | Lewandowski, Cutler T., Khan, Md.Wasim, BenAissa, Manel, Dubrovskyi, Oleksii, Ackerman-Berrier, Martha, LaDu, Mary Jo, Layden, Brian T., Thatcher, Gregory R.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010624/ https://www.ncbi.nlm.nih.gov/pubmed/33752129 http://dx.doi.org/10.1016/j.ebiom.2021.103287 |
Ejemplares similares
-
Remembering your A, B, C's: Alzheimer's disease and ABCA1
por: Lewandowski, Cutler T., et al.
Publicado: (2022) -
Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors
por: Siklos, Marton, et al.
Publicado: (2015) -
Interaction of oxidative stress and neurotrauma in ALDH2(−/−) mice causes significant and persistent behavioral and pro-inflammatory effects in a tractable model of mild traumatic brain injury
por: Knopp, Rachel C., et al.
Publicado: (2020) -
Transgenerational metabolomic fingerprints in mice ancestrally exposed to the obesogen TBT
por: Chamorro-García, Raquel, et al.
Publicado: (2021) -
Obesogens in Foods
por: Kladnicka, Iva, et al.
Publicado: (2022)